Medtronic touts positive 3-year results for the EverFlex self-expanding stent for treating peripheral artery disease it acquired when it bought Covidien for $50 billion.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1GpQjk0
Cap comentari:
Publica un comentari a l'entrada